Code | CSB-YP021000HU |
Abbreviation | Recombinant Human SEMA7A protein |
MSDS | |
Size | $368 |
Order now | |
Image | |
Have Questions? | Leave a Message or Start an on-line Chat |
The first step of making this recombinant Human SEMA7A protein is synthesizing the SEMA7A gene, the synthesized gene is then cloned into an expression vector which is a cDNA plasmid that includes a promoter sequence and an antibiotic-resistant gene. It also has N-terminal 6xHis tag encoding a fusion tag for downstream protein purification or identification. The antibiotic-resistant gene enables the selection of cells carrying the plasmid in antibiotic-based media and then transfects cells with a DNA vector that contains the template and then culturing the cells so that they transcribe and translate the desired protein. The recombinant SEMA7A protein is purified by ion-exchange chromatography or affinity purification. And the purity is 90%+ by SDS-PAGE.
SEMA7A plays a role in both innate and adaptive immune systems. It is a strong stimulator of monocytes in innate immunity, inducing the generation of pro-inflammatory cytokines. While SEMA7A works as a regulator of the T-cell immune response in adaptive immunity due to its effects on T-cell proliferation. SEMA7A can regulate T cell responses via the α1β1 integrin receptor. SEMA7A is a glycosylphosphatidylinositol (GPI)-anchored membrane protein with chemoattractant and chemorepulsive attributes. In addition to its role in guiding axon pathfinding during neuronal development, SEMA7A has diverse functions in morphogenesis and immune cell control.There are currently no reviews for this product.